Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents weeks ending February 9, 2019 (week 06)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current
week
Previous 52
weeks Max †
Cum YTD
2019 †
Cum YTD
2018 †
Current
week
Previous 52
weeks Max †
Cum YTD
2019 †
Cum YTD
2018 †
U.S. Residents, excluding U.S. Territories 202 678 2,049 3,947 5 13 37 46
New England 5 43 57 215 - 2 - 1
Connecticut - 13 2 51 - 0 - -
Maine 5 9 38 25 - 0 - -
Massachusetts - 17 - 100 - 2 - -
New Hampshire - 6 9 21 - 1 - 1
Rhode Island - 10 4 6 - 0 - -
Vermont - 5 4 12 - 1 - -
Middle Atlantic 48 104 312 523 - 4 8 4
New Jersey 4 30 67 140 - 3 7 -
New York (excluding New York City) 20 63 97 124 - 1 1 -
New York City 24 26 123 150 - 2 - -
Pennsylvania - 24 25 109 - 2 - 4
East North Central 27 118 366 623 1 3 10 14
Illinois N NC N N N NC N N
Indiana - 35 41 146 - 0 - -
Michigan - 37 54 120 - 2 - 5
Ohio 24 68 222 268 1 3 10 9
Wisconsin 3 22 49 89 - 0 - -
West North Central 15 40 147 290 2 6 9 11
Iowa N NC N N N NC N N
Kansas - 12 19 48 - 2 1 1
Minnesota - 3 - 8 - 0 - -
Missouri 10 26 95 166 1 5 6 9
Nebraska 3 7 21 35 1 1 2 1
North Dakota - 5 4 15 - 0 - -
South Dakota 2 6 8 18 - 1 - -
South Atlantic 48 123 378 682 - 2 4 7
Delaware 1 5 8 14 - 0 - -
District of Columbia 1 5 4 16 - 0 - -
Florida 17 24 90 133 - 2 2 2
Georgia 15 55 102 224 - 0 - -
Maryland 14 23 71 96 - 1 - 1
North Carolina N NC N N N NC N N
South Carolina - 23 83 136 - 1 2 4
Virginia - 2 3 4 - 1 - -
West Virginia - 10 17 59 - 1 - -
East South Central 10 76 204 485 1 1 2 -
Alabama 1 24 58 125 - 1 - -
Kentucky 6 22 69 76 1 1 1 -
Mississippi 3 19 49 71 - 0 - -
Tennessee - 31 28 213 - 1 1 -
West South Central 6 233 187 501 - 2 - 2
Arkansas 6 26 50 61 - 1 - -
Louisiana - 24 10 117 - 2 - -
Oklahoma N NC N N N NC N N
Texas - 195 127 323 - 2 - 2
Mountain 43 88 367 596 - 2 1 7
Arizona 19 36 154 229 - 2 - 7
Colorado 16 23 92 151 - 1 - -
Idaho N NC N N N NC N N
Montana 1 7 6 21 - 1 - -
Nevada - 13 26 53 - 1 - -
New Mexico 3 18 57 82 - 0 - -
Utah 4 9 31 50 - 1 1 -
Wyoming - 3 1 10 - 0 - -
Pacific - 11 31 32 1 1 3 -
Alaska - 7 19 17 1 1 3 -
California N NC N N N NC N N
Hawaii - 5 12 15 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - NC - NP - NC - NP
Total 202 678 2,049 3,947 5 13 37 46
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.